Artificial neural network classifier predicts neuroblastoma patients’ outcome

Gene Expression Signatures as Biomarkers of Tumour Hypoxia

(2015) B.H.L. Harris et al.   CLINICAL ONCOLOGY

Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical use

(2015) Kristoffer von Stedingk et al.   INTERNATIONAL JOURNAL OF CANCER

Cellular memory of hypoxia elicits neuroblastoma metastasis and enables invasion by non-aggressive neighbouring cells

(2015) A Herrmann et al.   Oncogenesis

Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patients

(2014) Davide Cangelosi et al.   BMC BIOINFORMATICS

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

(2014) A. Oberthuer et al.   CLINICAL CANCER RESEARCH

Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system

(2014) Thomas P. Stricker et al.   Molecular Oncology

Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients

(2013) Davide Cangelosi et al.   BMC BIOINFORMATICS

Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome

(2012) Andrea Cornero et al.   BMC BIOINFORMATICS

A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma

(2012) I. Garcia et al.   CLINICAL CANCER RESEARCH

Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma

(2012) Shahab Asgharzadeh et al.   JOURNAL OF CLINICAL ONCOLOGY

Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification

(2012) L. J. Valentijn et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

LIBSVM

(2012) Chih-Chung Chang et al.   ACM Transactions on Intelligent Systems and Technology

A 6-gene signature identifies four molecular subgroups of neuroblastoma

(2011) Frida Abel et al.   Cancer Cell International

A robust method for estimating gene expression states using Affymetrix microarray probe level data

(2010) Megu Ohtaki et al.   BMC BIOINFORMATICS

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene

(2010) F M Buffa et al.   BRITISH JOURNAL OF CANCER

Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics

(2010) Qun Lin et al.   CANCER BIOLOGY & THERAPY

Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature

(2010) K. De Preter et al.   CLINICAL CANCER RESEARCH

A Seven-Gene Set Associated with Chronic Hypoxia of Prognostic Importance in Hepatocellular Carcinoma

(2010) H. van Malenstein et al.   CLINICAL CANCER RESEARCH

Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis

(2010) X. Lu et al.   CLINICAL CANCER RESEARCH

Improved Survival of Children With Neuroblastoma Between 1979 and 2005: A Report of the Italian Neuroblastoma Registry

(2010) Riccardo Haupt et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Impact of Gene Expression–Based Classification for Neuroblastoma

(2010) André Oberthuer et al.   JOURNAL OF CLINICAL ONCOLOGY

A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients

(2010) Paolo Fardin et al.   Molecular Cancer

The l1-l2 regularization framework unmasks the hypoxia signature hidden in the transcriptome of a set of heterogeneous neuroblastoma cell lines

(2009) Paolo Fardin et al.   BMC GENOMICS

An introduction to artificial neural networks in bioinformatics--application to complex microarray and mass spectrometry datasets in cancer studies

(2009) L. J. Lancashire et al.   BRIEFINGS IN BIOINFORMATICS

ZNF423 Is Critically Required for Retinoic Acid-Induced Differentiation and Is a Marker of Neuroblastoma Outcome

(2009) Sidong Huang et al.   CANCER CELL

A Three-Gene Signature for Outcome in Soft Tissue Sarcoma

(2009) A.-C. Hoffmann et al.   CLINICAL CANCER RESEARCH

HIF-1  and HIF-2  Are Differentially Regulated In vivo in Neuroblastoma: High HIF-1  Correlates Negatively to Advanced Clinical Stage and Tumor Vascularization

(2009) R. Noguera et al.   CLINICAL CANCER RESEARCH

Coupling Logical Analysis of Data and Shadow Clustering for Partially Defined Positive Boolean Function Reconstruction

(2009) Marco Muselli et al.   IEEE TRANSACTIONS ON KNOWLEDGE AND DATA ENGINEERING

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

(2009) Joëlle Vermeulen et al.   LANCET ONCOLOGY

The role of hypoxia-inducible factors in tumorigenesis

(2008) E B Rankin et al.   CELL DEATH AND DIFFERENTIATION

Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy

(2008) Baldur Sveinbjörnsson et al.   FASEB JOURNAL

Regulation of cancer cell metabolism by hypoxia-inducible factor 1

(2008) Gregg L. Semenza   SEMINARS IN CANCER BIOLOGY